J&J Device Deal Sheds Light On OTC Skin Care Market
This article was originally published in The Tan Sheet
Johnson & Johnson Consumer Companies is entering the aesthetic laser market through a partnership with Palomar Medical announced Sept 7
You may also be interested in...
McNeil Consumer Health is seeking to leverage the potential Rx-to-OTC switch of J&J/Merck's Mevacor (lovastatin) with an agreement to license International Medical Innovations' predictive tests for coronary artery disease (CAD)
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning